| Identification | Back Directory | [Name]
Recombinant Human Cyclin-Dependent Kinase Inhibitor 2A | [CAS]
2332972-26-4 | [Synonyms]
MLM
ARF
CDN2
CMM2
TP16
MTS1
CDKN2
CD2A1
CDK4I
CDKN2A
p14ARF
p16-INK4
p16INK4A
HGNC:1787
ARF-INK4a
INK4a-ARF
RP23-166I8.5
p16-INK-4a human
p16-INK-4a TAT human
Multiple tumor suppressor 1
cyclin-dependent kinase inhibitor 2A
Anti-CDKN2A antibody produced in goat
Cyclin-dependent kinase 4 inhibitor A
Anti-p14 ARF antibody produced in rabbit
Cyclin-dependent kinase inhibitor 2A, isoform 4
ANTI-MLM(C-TERMINAL) antibody produced in rabbit
Anti-p16 INK, N-Terminal antibody produced in rabbit
Cyclin-dependent kinase inhibitor 2A, isoforms 1/2/3
Recombinant Human Cyclin-Dependent Kinase Inhibitor 2A
ANTI-PHOSPHO-P16-INK4A(S7) antibody produced in rabbit
ANTI-HP16-INK4A (N-TERM S7) antibody produced in rabbit
ANTI-P16INK4A (C-TERM E119) antibody produced in rabbit
ANTI-PHOSPHO-P16-INK4A(S140) antibody produced in rabbit
ANTI-PHOSPHO-P16-INK4A(S152) antibody produced in rabbit
cyclin-dependent kinase inhibitor 2A (melanoma, p16, inhibits CDK4) | [Molecular Formula]
C24H22FNO4S | [MDL Number]
MFCD02686484 | [MOL File]
2332972-26-4.mol | [Molecular Weight]
439.5 |
| Hazard Information | Back Directory | [Uses]
TP-16 is a novel and selective EP4 antagonist with an IC50 of 2.1 nM. | [General Description]
Anti-p14 ARF Antibody detects endogenous levels of total p14 ARF protein. | [IC 50]
EP4: 2.1 nM (IC50) | [References]
[1] Lu W, et al. Reprogramming immunosuppressive myeloid cells facilitates immunotherapy for colorectal cancer. EMBO Mol Med. 2021 Jan 11;13(1):e12798. DOI:10.15252/emmm.202012798 |
|
| Company Name: |
ZSGB-BIO
|
| Tel: |
02-400-810-9781 400810978 |
| Website: |
www.zsbio.com |
| Company Name: |
IQ Products
|
| Tel: |
1-0031505757000 0031505757000 |
| Website: |
www.iqproducts.nl |
| Company Name: |
Merck KGaA
|
| Tel: |
21-20338288 |
| Website: |
www.sigmaaldrich.cn |
|